PRESS RELEASE published on 09/15/2025 at 10:00, 1 year 1 month ago Lindis Blood Care Announces Publication of Final Results from Pivotal REMOVE Study with CATUVAB® in the Journal of Clinical Anesthesia Lindis Blood Care announces successful results of the pivotal REMOVE study with CATUVAB® in cancer surgery, demonstrating safety and efficacy in removing EpCAM-positive tumor cells from salvaged blood Lindis Blood Care REMOVE Study Cancer Surgery CATUVAB Transfusion Safety
PRESS RELEASE published on 09/15/2025 at 09:05, 1 year 1 month ago BioNxt Advances Semaglutide Oral Dissolvable Film (ODF) Program with Successful Proof-of-Concept and Prototype Development BioNxt achieves successful proof-of-concept trials for Semaglutide oral dissolvable film program, advancing to next development phase in GLP-1 market for diabetes and obesity therapies Drug Delivery Semaglutide BioNxt GLP-1 Market Proof-of-concept
PRESS RELEASE published on 09/15/2025 at 08:08, 1 year 1 month ago Ørsted publishes prospectus and initiates rights issue Ørsted initiates rights issue to raise capital for offshore wind projects. Offering includes 900,816,600 new shares at DKK 66.60 each. Underwritten and aims to strengthen financial foundation Rights Issue Ørsted Capital Raise Offshore Wind Projects Financial Underwriting
PRESS RELEASE published on 09/15/2025 at 08:06, 1 year 1 month ago EQS-Adhoc: CHAPTERS Group AG: Capital Increase against contribution in kind from Authorized Capital resolved CHAPTERS Group AG resolves capital increase from authorized capital by issuing new shares against contributions in kind. Share price set at EUR 35.00 per share Capital Increase Authorized Capital CHAPTERS Group AG New Shares EUR 35.00
PRESS RELEASE published on 09/15/2025 at 08:00, 1 year 1 month ago Transaction in Own Shares Molten Ventures plc (LSE: GROW) announces transaction in own shares on 12-Sep-2025. 50,000 Ordinary Shares purchased as part of the share repurchase program Share Repurchase Molten Ventures Plc Own Shares Transaction LSE: GROW
PRESS RELEASE published on 09/15/2025 at 08:00, 1 year 1 month ago DWK Deutsche Wasserkraft AG Signs Framework and Service Agreement for Development of Hydropower Plants with Total Annual Output of 95 GWh DWK Deutsche Wasserkraft AG signs agreement with OdelEnergy AS to develop hydropower plants in Norway with 95 GWh output. Initial investment EUR 50 million Norway DWK Deutsche Wasserkraft AG Hydropower Plants EUR 50 Million OdelEnergy AS
PRESS RELEASE published on 09/15/2025 at 08:00, 1 year 1 month ago Capital B confirms the acquisition of 48 BTC for EUR4.7 million, the holding of a total of 2,249 BTC, and a BTC Yield of 1,536.6% YTD Capital B confirms final completion of capital increase agreements with TOBAM and Fulgur Ventures, enabling acquisition of additional bitcoins. BTC Yield 1536.6% YTD, BTC Gain of 614.6, BTC € Gain of €60.6 million Bitcoin Holdings Fulgur Ventures TOBAM BTC Yield Capital B
PRESS RELEASE published on 09/15/2025 at 07:30, 1 year 1 month ago Trade Republic expands from Brokerage to Wealth Management – Invest into Private Markets from 1 euro. Start of strategic partnership with Apollo and EQT. Trade Republic expands from Brokerage to Wealth Management, partnering with Apollo and EQT. Customers can invest in Private Markets from 1 euro, offering unique diversification. Strategic move to democratize private investing for all European investors Wealth Management Private Markets EQT Trade Republic Apollo
PRESS RELEASE published on 09/15/2025 at 07:29, 1 year 1 month ago Ottobock plans Initial Public Offering in 2025 Ottobock SE & Co. KGaA plans an Initial Public Offering (IPO) in 2025, targeting EUR 100 million gross proceeds. The global MedTech leader in bionics is set to list on the Frankfurt Stock Exchange Frankfurt Stock Exchange IPO MedTech Ottobock Bionics
PRESS RELEASE published on 09/15/2025 at 07:00, 1 year 1 month ago Curatis: Double-digit growth in core business and development milestone achieved for C-PTBE-01 Curatis Holding AG reports double-digit revenue growth in H1 2025, signing a significant partnership with Phoenix Labs for C-PTBE-01. Financials show a loss due to increased development expenses for corticorelin Revenue Growth Partnership Financials Curatis Holding AG C-PTBE-01
Published on 10/15/2026 at 19:25, 49 minutes ago Datavault AI Highlights Data Futures Platform Patent Amid Tokenized Stock Exemption
Published on 10/15/2026 at 16:10, 4 hours 4 minutes ago North Shore Announces Extension to Falcon Property Option Agreement and Resource Stock Digest Engagement
Published on 10/15/2026 at 15:15, 4 hours 59 minutes ago Gold Terra to Host Community Town Hall Meeting in Yellowknife on October 21, 2026
Published on 10/15/2026 at 14:31, 5 hours 43 minutes ago First Breach to Present at the 20th Annual LD Micro Main Event
Published on 10/15/2026 at 14:05, 6 hours 9 minutes ago Innodata to Report Third Quarter 2026 Results
Published on 10/15/2026 at 18:03, 2 hours 11 minutes ago AIXTRON Q3 2026: Order intake and operating profitability significantly exceed market expectations
Published on 10/15/2026 at 18:00, 2 hours 14 minutes ago Supervisory Board appoints Dr. Marc-Alexander Mahl to the Fresenius Management Board and extends Sara Hennicken’s contract
Published on 10/15/2026 at 18:00, 2 hours 14 minutes ago EQS-Adhoc: AIXTRON Q3 2026: Order intake and operating profitability significantly exceed market expectations
Published on 10/15/2026 at 18:50, 1 hour 24 minutes ago September & first 9 months of 2026 traffic figures - Revision of Traffic assumptions for 2026
Published on 10/15/2026 at 17:45, 2 hours 29 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 10/15/2026 at 07:27, 12 hours 46 minutes ago Saint-Gobain strengthens its infrastructure offer in North America with the acquisition of D.S. Brown in construction chemicals